|
BUB3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.870200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.727200E-01 |
| Normal-vs-Stage2 |
9.975600E-01 |
| Normal-vs-Stage3 |
2.564400E-01 |
| Normal-vs-Stage4 |
3.272800E-01 |
| Stage1-vs-Stage2 |
9.830600E-01 |
| Stage1-vs-Stage3 |
1.889220E-01 |
| Stage1-vs-Stage4 |
3.016400E-01 |
| Stage2-vs-Stage3 |
3.923000E-01 |
| Stage2-vs-Stage4 |
3.691600E-01 |
| Stage3-vs-Stage4 |
1.257200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.953600E-01 |
| Normal-vs-AfricanAmerican |
7.532600E-01 |
| Normal-vs-Asian |
4.570000E-02 |
| Caucasian-vs-AfricanAmerican |
7.300400E-01 |
| Caucasian-vs-Asian |
2.019800E-01 |
| AfricanAmerican-vs-Asian |
5.175600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.556000E-01 |
| Normal-vs-Female |
9.493600E-01 |
| Male-vs-Female |
8.887200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.503200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.005600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.422600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.859820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.436200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.537600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.577030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.059000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.100970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.990400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.225500E-02 |
| Normal-vs-Grade 2 |
5.283600E-01 |
| Normal-vs-Grade 3 |
2.635400E-01 |
| Normal-vs-Grade 4 |
5.127600E-01 |
| Grade 1-vs-Grade 2 |
5.224100E-02 |
| Grade 1-vs-Grade 3 |
2.575700E-03 |
| Grade 1-vs-Grade 4 |
5.645000E-01 |
| Grade 2-vs-Grade 3 |
2.364200E-02 |
| Grade 2-vs-Grade 4 |
6.677800E-01 |
| Grade 3-vs-Grade 4 |
2.576400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.599170E-01 |
| Normal-vs-ccB subtype |
1.169380E-01 |
| ccA subtype-vs-ccB subtype |
1.579390E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.374400E-01 |
| Normal-vs-N1 |
3.924400E-01 |
| N0-vs-N1 |
6.059800E-01 |
|
|
